The impending publication of the fifth edition of the American Psychiatric Association's (APA) Diagnostic and Statistical Manual of Mental Disorders (DSM-V) next month may affect diagnosis rates of conditions such as Attention-Deficit/Hyperactivity Disorder (ADHD), both in the US and worldwide.
Published:
13-May-2013
|
New market entrants are set to defend the neurodegenerative diseases market from the looming patent cliff, leading global market revenue to increase from US$8.8 billion in 2012 to US$11 billion in 2018.
Published:
13-May-2013
|
While high disease prevalence is encouraging pharmaceuticals companies to enter into the ADHD market, a lack of understanding surrounding the condition is making drug development problematic.
Published:
30-Apr-2013
|
The Indian government’s plan to extend market-based pricing to all products listed in the National List of Essential Medicines (NLEM) will spark a price war and impair the recent expansion of the oncology therapeutics market.
Published:
16-Apr-2013
|
Rapid expansion in coverage over the coming years will see the Filipino seasonal influenza vaccine market quadruple in size by 2018.
Published:
16-Apr-2013
|
Over a million new cases of cancer are diagnosed globally per year, and the disease burden is expected to rise as elderly populations grow across many countries and unhealthy lifestyles remain commonplace. However, cancer vaccines, the latest treatment option, may be restricted to the developed counties due to their high price.
Published:
28-Mar-2013
|
Cancer vaccines may have something to offer both early-stage and late-stage cancer patients, as a therapeutic option to significantly delay disease progression and increase overall survival.
Published:
27-Mar-2013
|
Developing new vaccine products is a costly, lengthy and uncertain process, but the resounding success of the first blockbuster vaccine is making healthcare companies sit up and take notice of this potential goldmine.
Published:
21-Mar-2013
|
Pharmaceutical giants GlaxoSmithKline (GSK) and Merck are fighting it out in the vaccination market, as countries pick sides in their cervical cancer vaccination programs.
Published:
21-Mar-2013
|
China remains an attractive target for pharmaceutical research and manufacturing, and major players from around the world are flocking to benefit from cut-price production.
Published:
18-Mar-2013
|
The opioid pain management market will continue to evolve over the coming years with new products and post-marketing studies that aim to reduce the risk of abuse.
Published:
14-Feb-2013
|
Since 2004, the market for mAbs in Rheumatoid Arthritis (RA) has experienced tremendous growth, and it is on the verge of entering a historically unprecedented scenario over the next six years.
Published:
11-Feb-2013
|
India is the second diabetes capital of the world after China, with the treatment market growing at a double-digit year-on-year growth rate, presenting both domestic and Multinational Companies (MNCs) with promising opportunities.
Published:
05-Feb-2013
|
Physicians treating rare blood disorders are gaining more drug treatments to choose from, which allow patients to avoid demanding surgeries and chemotherapy, and fill the pockets of pharmaceutical companies who can charge top dollar in these untapped markets.
Published:
05-Feb-2013
|
The introduction of generic statins has kick-started a decline that will see the global statins market lose over US$7 billion in revenue by 2018.
Published:
29-Jan-2013
|
The increasing number of consolidations and in-licensing agreements between Multinational Corporations (MNC) and Indian companies highlights the growing significance of the country’s pharmaceutical market.
Published:
25-Jan-2013
|
The global population grows older while increasing social pressures drive individuals to look younger, and consumer awareness has risen for cosmeceutical products which offer a way to keep up appearances without going under the knife.
Published:
22-Jan-2013
|
Generally unimpressive treatment line-ups combined with weak product pipelines will lead to modest growth for several inherited orphan blood disease markets.
Published:
22-Jan-2013
|
Hepatocellular carcinoma (HCC), the most common form of liver cancer, carries a deadly reputation, and patients face shrinking hopes of new treatment options as drug trials hit problems.
Published:
17-Jan-2013
|
The stem cell therapy market in Asia-Pacific is poised to offer significant contributions in the future, thanks to renewed interest by the respective governments of India, China, Japan, South Korea and Singapore to provide cures for a range of diseases.
Published:
19-Dec-2012
|
Despite healthy sales of key medications and the positive market impact of an expanding geriatric population, growth in the global rheumatology therapeutics market is expected to slow in the near future due to the entry of biosimilars.
Published:
13-Dec-2012
|
Huge rewards and strong competition are prompting generic drug manufacturers to closely examine the best way to maximize market share as the industry patent cliff approaches its peak.
Published:
28-Nov-2012
|
A growing elderly population, rising obesity and a huge number of smokers are key contributors to a surging Over-The-Counter (OTC) drugs market in Russia.
Published:
23-Nov-2012
|
The Chinese market for Over-The-Counter (OTC) drugs will almost double in size by 2018, with the country’s swelling obesity rate a key contributor.
Published:
23-Nov-2012
|
Rising healthcare costs and phenomenal waste in the US healthcare system is forcing health services and industry players to re-think how care is delivered.
Published:
20-Nov-2012
|